November 26 | Hong Kong Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend the 2026 Capital Market Hong Kong Forum in Hong Kong and will deliver a keynote speech from 13:20 to 14:30 on November 26. (IMAGE)
Caption
Dr. Zhavoronkov will delve into how artificial intelligence is transitioning from cutting-edge technological breakthroughs to large-scale commercial applications, and analyze the profound impact and new opportunities this trend brings to global investors and the asset management industry.
Credit
Insilico Medicine
Usage Restrictions
None
License
Original content